TH07 - A New Novel Topical Treatment for Androgenic Alopecia Treatment 7/18/2024
Triple Hair Inc. developed a new topical treatment, TH07, combining Finasteride, Latanoprost, and Minoxidil for androgenic alopecia. Users discussed its effectiveness compared to other treatments and shared their own product combinations.
View this post in the Community →
Similar Community Posts Join
2 / 3 resultscommunity New company bringing Minoxidil + Finasteride + Bimatoprost topical to market
A new company is introducing a topical treatment combining Minoxidil, Finasteride, and Bimatoprost for hair loss. Users are also inquiring about updates on a minoxidil-enhancing shampoo from Applied Biology.
community Target Area Hair Count (TAHC) increase comparasion of all future treatments in clinical trial phases
Finasteride, Minoxidil, Bioneer CosmeRNA, Technoderma, Kintor, Hope, Breezula, and Follicum treatments showed increases in hair count, with Technoderma showing the highest increase at 24.3 hairs/cm². Amplifica has not yet published results.
Related Research
3 / 3 results
research Satisfaction of Patients with Androgenetic Alopecia from a Topical Treatment with TH07 - A Novel Combination of Substances That Safely Encourage Hair Growth
TH07 treatment is promising for hair growth, with higher satisfaction in males.
research TH07 - A New Novel Topical Treatment for Androgenic Alopecia
TH07 is a topical combination of finasteride, latanoprost, and minoxidil, and shows promise.
research Cyclosporine A-Induced Intracranial Thrombotic Complications: Systematic Review and Case Report
Cyclosporine-A can cause serious blood clots in the brain, so patients need careful monitoring.